What You Should Know:
- Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments.
- Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Geneial Receives $2.3M NIH Grant for Decentralized Biomedical Data Platform
What You Should Know:
- Digital health company Geneial announces a $2.3M grant from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.
- Geneial will use $2.3M NIH award to build private, decentralized data platform facilitating research of genetic diseases. Geneial's platform will connect researchers of rare genetic diseases with relevant data while preserving patient privacy. Geneial's platform aims to help researchers leverage
Read More
Bicycle Health Nabs $5M to Scale Its Virtual Opioid Use Disorder Treatment
What You Should Know:
- Bicycle Health, a Boston, MA-based provider of virtual opioid addiction treatment secures $5M from Cobalt Ventures to further accelerate the expansion of its telehealth opioid use disorder (OUD) treatment.
- The additional capital extends Bicycle Health’s Series B venture capital financing, bringing the company’s total funding to date to $83M.
Evidence-based, online suboxone treatment for opioid addiction
Founded in 2017, Bicycle
Read More
Surge Raises $2.6M for Blood Test to Predict Post-Surgery Complications
What You Should Know:
- Biotech and medical AI innovator Surge announced a $2.6M round co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture Partners, a leading fund based in the Silicon Valley . Veteran angel investors, including Nicolas Godin, the COO/CFO of Cardiologs, also participated in the round.
- Based on an exclusive license to Stanford's patented postoperative complication prediction technology, Surge's flagship product
Read More
OurCrowd Launches $200M Global Health Equity Fund
OurCrowd Launches $200M Global Health Equity Fund
What You Should Know:
- Global venture firm OurCrowd launches the $200M Global Health Equity Fund (GHEF) in collaboration with the WHO Foundation.
- The fund team will be led by OurCrowd CEO, Jon Medved, and OurCrowd Managing Partner, Dr. Morris Laster, with the support of the WHO Foundation’s Chief Impact Investment Officer, Geetha Tharmaratnam. It will be managed by an OurCrowd team of clinical experts with decades of experience in
Read More
Scratch Financial Raises $35M for Patient Financing Solution
What You Should Know:
- Today Scratch Financial, an LA-based financial technology company connecting patients andmedical practices in the care now, pay later economy announced it has raised $35M in Series C funding led by Norwest Venture Partners.
- Scratch, a business-to-business buy-now-pay-later (BNPL) fintech company helps patients focus on what’s most important - caring now - for themselves or for their pet - and paying later in a way that better meets their needs.
Simplest
Read More
Lyfegen Raises $8M for Value-Based Contracting for High-Cost Drugs
What You Should Know:
- Lyfegen, a global health tech SaaS company driving the world’s transition from volume to value-based healthcare for high-cost drugs raises $8M in Series A financing round led by aMoon, with additional participation from APEX Ventures and others.
- Lyfegen’s value-based contracting software is used by healthcare payers and leading pharma companies, including Novartis, Roche, MSD, Bristol Myers Squibb (BMS) and Johnson & Johnson.
Value-Based
Read More
Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies
What You Should Know:
- Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function.
- The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and
Read More
Zócalo Health Raises $5M to Launch Primary Care Services for Latinos
What You Should Know:
Zócalo Health, a Latino-founded healthcare service designed for Latino patients, announced that it’s closed on $5M in seed funding to support its launch of virtual primary care services in California, Texas, and Washington this year.
The seed funding was co-led by Animo Ventures, Virtue, and Vamos Ventures. The round includes other notable investors including Necessary Ventures, Able Partners, and angel investors Toyin Ajayi, Freada Kapor Klein, Nikhil
Read More
HCA Makes Strategic Investment in Cardiac Monitoring Wearable VitalConnect
What You Should Know:
- VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, has just announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one of the nation’s leading healthcare providers.
- The investment will go toward further accelerating VitalConnect’s rapidly growing cardiac monitoring business segment while advancing key Remote Patient Monitoring of individuals who
Read More
